Advanced Solid and Hematological TP53wt Tumors
1 clinical trials · Condition
◉ Watch Advanced Solid and Hematological TP53wt Tumors
| Record | Firm | Date |
|---|---|---|
| Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt (NCT02143635) | Novartis Pharmaceuticals | 2014-07-07 |
Track Advanced Solid and Hematological TP53wt Tumors automatically
Every clearance here is in the API, with alerts when new ones post.